Cassava Bolts To Record High After Alzheimer's Drug Improves Cognition
Cassava Sciences said Thursday its Alzheimer's treatment showed promise in a six-month study and SAVA stock bolted to a record high.
Cassava Sciences ( SAVA ) said Thursday its Alzheimer's treatment showed promise in a six-month study and SAVA stock bolted to a record high.
-------------------------
TP01 = 92,47000$
TP02 = 112,85000$
TP03 = 133,23000$
TP04 = 153,61000$
TP05 = 173,99000$
Cassava Sciences said Thursday its Alzheimer's treatment showed promise in a six-month study and SAVA stock bolted to a record high.
Cassava Sciences ( SAVA ) said Thursday its Alzheimer's treatment showed promise in a six-month study and SAVA stock bolted to a record high.
-------------------------
TP01 = 92,47000$
TP02 = 112,85000$
TP03 = 133,23000$
TP04 = 153,61000$
TP05 = 173,99000$